News
The Houston-based Empower Pharmacy is seeking to dismiss a lawsuit that targets its ability to sell popular diabetes and ...
Houston’s life sciences real estate market is growing again — this time with a 21.3-acre mixed-use district aimed at biotech ...
The Houston-based compounding pharmacy rejected Lilly's claims of false advertising in a New Jersey federal court. © 2025 American City Business Journals. All rights ...
A major pharmaceutical manufacturing company is considering planting ground in Houston, with a $5.7 billion proposed investment into a new facility. Eli Lilly applied for a tax abatement under ...
Eli Lilly was already in negotiations “with several states” at the time of that announcement and invited additional interest. Despite the tax incentive application, the Houston project isn't ...
HOUSTON — Eli Lilly & Co. (NYSE: LLY), one of the largest pharmaceutical manufacturers in the world, could be the latest major manufacturer moving into Houston. The Indianapolis-based drugmaker ...
Eli Lilly and Co. is considering Houston as a location for one of its four planned new U.S. manufacturing sites, with the Texas city potentially landing a $5.9 billion facility that could employ ...
Eli Lilly is jockeying for a tax break in Texas as it weighs whether to build a $5.9 billion active pharmaceutical ingredient (API) manufacturing facility in Houston, according to a recent filing ...
One of the world’s largest drugmakers is sizing up a massive bet on Houston. Pharma giant Eli Lilly is planning a $5.9 billion investment for a massive pharmaceutical manufacturing facility in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results